메뉴 건너뛰기




Volumn 7, Issue 5, 2013, Pages 443-453

Diagnosis of acromegaly: State of the art

Author keywords

Acromegaly; Growth hormone; Insulin like growth factor 1

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GHRELIN; PEGVISOMANT; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; HUMAN GROWTH HORMONE;

EID: 84883183810     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2013.820181     Document Type: Article
Times cited : (8)

References (103)
  • 1
    • 0018891451 scopus 로고
    • Epidemiology of acromegaly in the newcastle region
    • Alexander L, Appleton D, Hall R, et al. Epidemiology of acromegaly in the newcastle region. Clin Endocrinol (Oxf ) 1980;12:71-9
    • (1980) Clin Endocrinol (Oxf , vol.12 , pp. 71-79
    • Alexander, L.1    Appleton, D.2    Hall, R.3
  • 2
    • 33845489470 scopus 로고    scopus 로고
    • High prevalence of pituitary adenomas: A cross-sectional study in the province of liege, belgium
    • Daly AF, Rixhon M, Adam C, et al. High prevalence of pituitary adenomas: A cross-sectional study in the province of liege, belgium. J Clin Endocrinol Metab 2006;91:4769-75
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 4769-4775
    • Daly, A.F.1    Rixhon, M.2    Adam, C.3
  • 3
    • 80053927915 scopus 로고    scopus 로고
    • Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population
    • Rosario PW. Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population. Pituitary 2011;14:217-21
    • (2011) Pituitary , vol.14 , pp. 217-221
    • Rosario, P.W.1
  • 4
    • 0027989713 scopus 로고
    • Determinants of clinical outcome and survival in acromegaly
    • Rajasoorya C, Holdaway IM, Wrightson P, et al. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf ) 1994;41:95-102
    • (1994) Clin Endocrinol (Oxf , vol.41 , pp. 95-102
    • Rajasoorya, C.1    Holdaway, I.M.2    Wrightson, P.3
  • 5
    • 0023886723 scopus 로고
    • Epidemiology and long-term survival in acromegaly A study of 166 cases diagnosed between 1955 and 1984
    • Bengtsson BA, Eden S, Ernest I, et al. Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med Scand 1988;223:327-35
    • (1988) Acta Med Scand , vol.223 , pp. 327-335
    • Bengtsson, B.A.1    Eden, S.2    Ernest, I.3
  • 6
    • 0031774361 scopus 로고    scopus 로고
    • Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly
    • Swearingen B, Barker FG II, Katznelson L, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3419-26
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 3419-3426
    • Swearingen, B.1    Barker, I.I.F.G.2    Katznelson, L.3
  • 7
    • 49649124901 scopus 로고    scopus 로고
    • A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
    • Holdaway IM, Bolland MJ, Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol 2008;159:89-95
    • (2008) Eur J Endocrinol , vol.159 , pp. 89-95
    • Holdaway, I.M.1    Bolland, M.J.2    Gamble, G.D.3
  • 8
    • 84948721761 scopus 로고
    • Histochemical characterization of the cutaneous involvement of acromegaly
    • Matsuoka LY, Wortsman J, Kupchella CE, et al. Histochemical characterization of the cutaneous involvement of acromegaly. Arch Intern Med 1982;142:1820-3
    • (1982) Arch Intern Med , vol.142 , pp. 1820-1823
    • Matsuoka, L.Y.1    Wortsman, J.2    Kupchella, C.E.3
  • 9
    • 0020310068 scopus 로고
    • The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours
    • Jadresic A, Banks LM, Child DF, et al. The acromegaly syndrome. relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q J Med 1982;51:189-204
    • (1982) Q J Med , vol.51 , pp. 189-204
    • Jadresic, A.1    Banks, L.M.2    Child, D.F.3
  • 10
    • 79960108314 scopus 로고    scopus 로고
    • A novel approach to the detection of acromegaly: Accuracy of diagnosis by automatic face classification
    • Schneider HJ, Kosilek RP, Gunther M, et al. A novel approach to the detection of acromegaly: Accuracy of diagnosis by automatic face classification. J Clin Endocrinol Metab 2011;96:2074-80
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 2074-2080
    • Schneider, H.J.1    Kosilek, R.P.2    Gunther, M.3
  • 12
    • 76149126990 scopus 로고    scopus 로고
    • Endocrine aspects of obstructive sleep apnea
    • Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab 2010;95:483-95
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 483-495
    • Attal, P.1    Chanson, P.2
  • 13
    • 84874860258 scopus 로고    scopus 로고
    • A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy
    • Annamalai AK, Webb A, Kandasamy N, et al. A comprehensive study of clinical, biochemical, radiological, vascular, cardiac, and sleep parameters in an unselected cohort of patients with acromegaly undergoing presurgical somatostatin receptor ligand therapy. J Clin Endocrinol Metab 2013;98:1040-50
    • (2013) J Clin Endocrinol Metab , vol.98 , pp. 1040-1050
    • Annamalai, A.K.1    Webb, A.2    Kandasamy, N.3
  • 14
    • 18844370346 scopus 로고    scopus 로고
    • Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life
    • Biermasz NR, Pereira AM, Smit JW, et al. Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 2005;90:2731-9
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 2731-2739
    • Biermasz, N.R.1    Pereira, A.M.2    Smit, J.W.3
  • 15
    • 0034254774 scopus 로고    scopus 로고
    • The pathology of median neuropathy in acromegaly
    • Jenkins PJ, Sohaib SA, Akker S, et al. The pathology of median neuropathy in acromegaly. Ann Intern Med 2000;133:197-201
    • (2000) Ann Intern Med , vol.133 , pp. 197-201
    • Jenkins, P.J.1    Sohaib, S.A.2    Akker, S.3
  • 16
    • 26644464576 scopus 로고    scopus 로고
    • Hypertension in acromegaly and in the normal population: Prevalence and determinants
    • Vitale G, Pivonello R, Auriemma RS, et al. Hypertension in acromegaly and in the normal population: Prevalence and determinants. Clin Endocrinol (Oxf ) 2005;63:470-6
    • (2005) Clin Endocrinol (Oxf , vol.63 , pp. 470-476
    • Vitale, G.1    Pivonello, R.2    Auriemma, R.S.3
  • 17
    • 1542269637 scopus 로고    scopus 로고
    • Prevalence and determinants of left ventricular hypertrophy in acromegaly: Impact of different methods of indexing left ventricular mass
    • Vitale G, Galderisi M, Pivonello R, et al. Prevalence and determinants of left ventricular hypertrophy in acromegaly: Impact of different methods of indexing left ventricular mass. Clin Endocrinol( Oxf ) 2004;60:343-9
    • (2004) Clin Endocrinol( Oxf , vol.60 , pp. 343-349
    • Vitale, G.1    Galderisi, M.2    Pivonello, R.3
  • 18
    • 80054802844 scopus 로고    scopus 로고
    • Determinants of cardiac disease in newly diagnosed patients with acromegaly: Results of a 10 year survey study
    • Colao A, Pivonello R, Grasso LF, et al. Determinants of cardiac disease in newly diagnosed patients with acromegaly: Results of a 10 year survey study. Eur J Endocrinol 2011;165:713-21
    • (2011) Eur J Endocrinol , vol.165 , pp. 713-721
    • Colao, A.1    Pivonello, R.2    Grasso, L.F.3
  • 19
    • 8744228134 scopus 로고    scopus 로고
    • Long-term outcome of patients with acromegaly and congestive heart failure
    • Bihan H, Espinosa C, Valdes-Socin H, et al. Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab 2004;89:5308-13
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 5308-5313
    • Bihan, H.1    Espinosa, C.2    Valdes-Socin, H.3
  • 20
    • 39149139330 scopus 로고    scopus 로고
    • Acromegaly: Re-thinking the cancer risk
    • Loeper S, Ezzat S. Acromegaly: Re-thinking the cancer risk. Rev Endocr Metab Disord 2008;9:41-58
    • (2008) Rev Endocr Metab Disord , vol.9 , pp. 41-58
    • Loeper, S.1    Ezzat, S.2
  • 21
    • 33845491265 scopus 로고    scopus 로고
    • Medical progress: Acromegaly
    • Melmed S. Medical progress: Acromegaly. N Engl J Med 2006;355:2558-73
    • (2006) N Engl J Med , vol.355 , pp. 2558-2573
    • Melmed, S.1
  • 22
    • 49249115728 scopus 로고    scopus 로고
    • Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
    • Rokkas T, Pistiolas D, Sechopoulos P, et al. Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis. World J Gastroenterol 2008;14:3484-9
    • (2008) World J Gastroenterol , vol.14 , pp. 3484-3489
    • Rokkas, T.1    Pistiolas, D.2    Sechopoulos, P.3
  • 23
    • 0036802441 scopus 로고    scopus 로고
    • British society for gastroenterology association of coloproctology for great britain and ireland screening guidelines for colorectal cancer and polyps in patients with acromegaly
    • Jenkins PJ, Fairclough PD; British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Screening guidelines for colorectal cancer and polyps in patients with acromegaly. Gut 2002;51:V13-14
    • (2002) Gut , vol.51
    • Jenkins, P.J.1    Fairclough, P.D.2
  • 24
    • 84873742122 scopus 로고    scopus 로고
    • Thyroid cancer in patients with acromegaly: A case-control study
    • dos Santos MC, Nascimento GC, Nascimento AG, et al. Thyroid cancer in patients with acromegaly: A case-control study. Pituitary 2013;16:109-14
    • (2013) Pituitary , vol.16 , pp. 109-114
    • Dos Santos, M.C.1    Nascimento, G.C.2    Nascimento, A.G.3
  • 25
    • 77955895409 scopus 로고    scopus 로고
    • Thyroid cancer is the most common cancer associated with acromegaly
    • Gullu BE, Celik O, Gazioglu N, et al. Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 2010;13:242-8
    • (2010) Pituitary , vol.13 , pp. 242-248
    • Gullu, B.E.1    Celik, O.2    Gazioglu, N.3
  • 27
    • 0036462174 scopus 로고    scopus 로고
    • Oncological complications of excess GH in acromegaly
    • Webb SM, Casanueva F, Wass JA. Oncological complications of excess GH in acromegaly. Pituitary 2002;5:21-5
    • (2002) Pituitary , vol.5 , pp. 21-25
    • Webb, S.M.1    Casanueva, F.2    Wass, J.A.3
  • 28
    • 77954845856 scopus 로고    scopus 로고
    • Mortality in patients with pituitary disease
    • Sherlock M, Ayuk J, Tomlinson JW, et al. Mortality in patients with pituitary disease. Endocr Rev 2010;31:301-42
    • (2010) Endocr Rev , vol.31 , pp. 301-342
    • Sherlock, M.1    Ayuk, J.2    Tomlinson, J.W.3
  • 29
    • 7244257406 scopus 로고    scopus 로고
    • Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the spanish acromegaly registry (registro espanol de acromegalia, REA
    • Mestron A, Webb SM, Astorga R, et al. Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the spanish acromegaly registry (registro espanol de acromegalia, REA). Eur J Endocrinol 2004;151:439-46
    • (2004) Eur J Endocrinol , vol.151 , pp. 439-446
    • Mestron, A.1    Webb, S.M.2    Astorga, R.3
  • 30
    • 0034037529 scopus 로고    scopus 로고
    • Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients
    • Kasayama S, Otsuki M, Takagi M, et al. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol( Oxf ) 2000;52:549-55
    • (2000) Clin Endocrinol( Oxf , vol.52 , pp. 549-555
    • Kasayama, S.1    Otsuki, M.2    Takagi, M.3
  • 31
    • 79957784185 scopus 로고    scopus 로고
    • Diabetes in acromegaly, prevalence, risk factors, and evolution: Data from the french acromegaly registry
    • Fieffe S, Morange I, Petrossians P, et al. Diabetes in acromegaly, prevalence, risk factors, and evolution: Data from the french acromegaly registry. Eur J Endocrinol 2011;164:877-84
    • (2011) Eur J Endocrinol , vol.164 , pp. 877-884
    • Fieffe, S.1    Morange, I.2    Petrossians, P.3
  • 32
    • 84872073482 scopus 로고    scopus 로고
    • The metabolic profile in active acromegaly is gender-specific
    • Ciresi A, Amato MC, Pivonello R, et al. The metabolic profile in active acromegaly is gender-specific. J Clin Endocrinol Metab 2013;98:E51-9
    • (2013) J Clin Endocrinol Metab , vol.98
    • Ciresi, A.1    Amato, M.C.2    Pivonello, R.3
  • 34
    • 84871951676 scopus 로고    scopus 로고
    • Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: Case reports and review of the literature
    • Shah R, Licata A, Oyesiku NM, et al. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: Case reports and review of the literature. Pituitary 2012;15:S17-22
    • (2012) Pituitary , vol.15
    • Shah, R.1    Licata, A.2    Oyesiku, N.M.3
  • 35
    • 33644822471 scopus 로고    scopus 로고
    • Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity
    • White HD, Ahmad AM, Durham BH, et al. Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity. J Clin Endocrinol Metab 2006;91:913-19
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 913-919
    • White, H.D.1    Ahmad, A.M.2    Durham, B.H.3
  • 36
    • 18644379128 scopus 로고    scopus 로고
    • Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: Distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia
    • Ueda M, Inaba M, Tahara H, et al. Hypercalcemia in a patient with primary hyperparathyroidism and acromegaly: Distinct roles of growth hormone and parathyroid hormone in the development of hypercalcemia. Intern Med 2005;44:307-10
    • (2005) Intern Med , vol.44 , pp. 307-310
    • Ueda, M.1    Inaba, M.2    Tahara, H.3
  • 37
    • 0025816183 scopus 로고
    • The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy
    • Matucci-Cerinic M, Lotti T, Jajic I, et al. The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine (Baltimore) 1991;70:208-14
    • (1991) Medicine (Baltimore , vol.70 , pp. 208-214
    • Matucci-Cerinic, M.1    Lotti, T.2    Jajic, I.3
  • 38
    • 84877107417 scopus 로고    scopus 로고
    • Primary hypothyroidism presenting as pseudoacromegaly
    • Kumar KV, Shaikh A, Anwar I, et al. Primary hypothyroidism presenting as pseudoacromegaly. Pituitary 2012;15:S49-52
    • (2012) Pituitary , vol.15
    • Kumar, K.V.1    Shaikh, A.2    Anwar, I.3
  • 39
    • 84883163449 scopus 로고    scopus 로고
    • Acromegaloid facial appearance: Case report and literature review
    • Ghazi A, Khosla S, Becker K. Acromegaloid facial appearance: Case report and literature review. Case Rep Endocrinol 2013;2013:970396
    • (2013) Case Rep Endocrinol , vol.2013 , pp. 970396
    • Ghazi, A.1    Khosla, S.2    Becker, K.3
  • 40
    • 10244245501 scopus 로고    scopus 로고
    • Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly
    • Kumar S, Durrington PN, ORahilly S, et al. Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocrinol Metab 1996;81:3465-8
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 3465-3468
    • Kumar, S.1    Durrington, P.N.2    Orahilly, S.3
  • 41
    • 79959248640 scopus 로고    scopus 로고
    • Insulin-mediated pseudoacromegaly
    • Sam AH, Tan T, Meeran K. Insulin-mediated "pseudoacromegaly". Hormones (Athens) 2011;10:156-61
    • (2011) Hormones (Athens , vol.10 , pp. 156-161
    • Sam, A.H.1    Tan, T.2    Meeran, K.3
  • 42
    • 84856282107 scopus 로고    scopus 로고
    • American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update: Executive summary
    • Katznelson L, Atkinson JL, Cook DM, et al. American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update: Executive summary. Endocr Pract 2011;17:636-46
    • (2011) Endocr Pract , vol.17 , pp. 636-646
    • Katznelson, L.1    Atkinson, J.L.2    Cook, D.M.3
  • 43
    • 84871366665 scopus 로고    scopus 로고
    • Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone
    • Subbarayan SK, Fleseriu M, Gordon MB, et al. Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocr Pract 2012;18:817-25
    • (2012) Endocr Pract , vol.18 , pp. 817-825
    • Subbarayan, S.K.1    Fleseriu, M.2    Gordon, M.B.3
  • 44
    • 10744225758 scopus 로고    scopus 로고
    • Serum insulin-like growth factor i reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study
    • Brabant G, von zur Muhlen A, Wuster C, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: Results from a multicenter study. Horm Res 2003;60:53-60
    • (2003) Horm Res , vol.60 , pp. 53-60
    • Brabant, G.1    Von Zur Muhlen, A.2    Wuster, C.3
  • 45
    • 14044272879 scopus 로고    scopus 로고
    • Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity
    • Gleeson HK, Lissett CA, Shalet SM. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. J Clin Endocrinol Metab 2005;90:1061-7
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 1061-1067
    • Gleeson, H.K.1    Lissett, C.A.2    Shalet, S.M.3
  • 47
    • 33744523193 scopus 로고    scopus 로고
    • Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects
    • Schneider HJ, Saller B, Klotsche J, et al. Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur J Endocrinol 2006;15:699-706
    • (2006) Eur J Endocrinol , vol.15 , pp. 699-706
    • Schneider, H.J.1    Saller, B.2    Klotsche, J.3
  • 48
    • 61849158161 scopus 로고    scopus 로고
    • Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults
    • Berrigan D, Potischman N, Dodd KW, et al. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res 2009;19:146-55
    • (2009) Growth Horm IGF Res , vol.19 , pp. 146-155
    • Berrigan, D.1    Potischman, N.2    Dodd, K.W.3
  • 49
    • 84861982113 scopus 로고    scopus 로고
    • Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes
    • vii-viii
    • Clemmons DR. Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes. Endocrinol Metab Clin North Am 2012;41:425-43. vii-viii
    • (2012) Endocrinol Metab Clin North Am , vol.41 , pp. 425-443
    • Clemmons, D.R.1
  • 51
    • 34249869743 scopus 로고    scopus 로고
    • Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice
    • Pokrajac A, Wark G, Ellis AR, et al. Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice. Clin Endocrinol (Oxf ) 2007;67:65-70
    • (2007) Clin Endocrinol (Oxf , vol.67 , pp. 65-70
    • Pokrajac, A.1    Wark, G.2    Ellis, A.R.3
  • 52
    • 0037502831 scopus 로고    scopus 로고
    • A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum
    • Chen JW, Ledet T, Orskov H, et al. A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. Am J Physiol Endocrinol Metab 2003;284:E1149-55
    • (2003) Am J Physiol Endocrinol Metab , vol.284
    • Chen, J.W.1    Ledet, T.2    Orskov, H.3
  • 53
    • 47549110969 scopus 로고    scopus 로고
    • Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: Comparison with five widely used IGF-I immunoassays
    • Brugts MP, Ranke MB, Hofland LJ, et al. Normal values of circulating insulin-like growth factor-I bioactivity in the healthy population: Comparison with five widely used IGF-I immunoassays. J Clin Endocrinol Metab 2008;93:2539-45
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 2539-2545
    • Brugts, M.P.1    Ranke, M.B.2    Hofland, L.J.3
  • 54
    • 84875139918 scopus 로고    scopus 로고
    • Soluble alpha-klotho: A novel serum biomarker for the activity of GH-producing pituitary adenomas
    • Neidert MC, Sze L, Zwimpfer C, et al. Soluble alpha-klotho: A novel serum biomarker for the activity of GH-producing pituitary adenomas. Eur J Endocrinol 2013;168:575-83
    • (2013) Eur J Endocrinol , vol.168 , pp. 575-583
    • Neidert, M.C.1    Sze, L.2    Zwimpfer, C.3
  • 55
    • 84862646695 scopus 로고    scopus 로고
    • Excessively high soluble klotho in patients with acromegaly
    • Sze L, Bernays RL, Zwimpfer C, et al. Excessively high soluble klotho in patients with acromegaly. J Intern Med 2012;272:93-7
    • (2012) J Intern Med , vol.272 , pp. 93-97
    • Sze, L.1    Bernays, R.L.2    Zwimpfer, C.3
  • 56
    • 0033818901 scopus 로고    scopus 로고
    • Clinical and reimbursement issues in growth hormone use in adults
    • Biller BM, Vance ML, Kleinberg DL, et al. Clinical and reimbursement issues in growth hormone use in adults. Am J Manag Care 2000;6:S817-27
    • (2000) Am J Manag Care , vol.6
    • Biller, B.M.1    Vance, M.L.2    Kleinberg, D.L.3
  • 57
    • 0023684610 scopus 로고
    • Plasma insulin-like growth factor-I/ somatomedin-C in acromegaly: Correlation with the degree of growth hormone hypersecretion
    • Barkan AL, Beitins IZ, Kelch RP. Plasma insulin-like growth factor-I/ somatomedin-C in acromegaly: Correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 1988;67:69-73
    • (1988) J Clin Endocrinol Metab , vol.67 , pp. 69-73
    • Barkan, A.L.1    Beitins, I.Z.2    Kelch, R.P.3
  • 58
    • 18844375867 scopus 로고    scopus 로고
    • Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein( IGFBP)-1 to IGFBP-4: Implications for cardiovascular risk
    • Heald A, Kaushal K, Anderson S, et al. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein( IGFBP)-1 to IGFBP-4: Implications for cardiovascular risk. Gynecol Endocrinol 2005;20:176-82
    • (2005) Gynecol Endocrinol , vol.20 , pp. 176-182
    • Heald, A.1    Kaushal, K.2    Anderson, S.3
  • 59
    • 42049103897 scopus 로고    scopus 로고
    • Growth hormone response during oral glucose tolerance test: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index
    • Arafat AM, Mohlig M, Weickert MO, et al. Growth hormone response during oral glucose tolerance test: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab 2008;93:1254-62
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 1254-1262
    • Arafat, A.M.1    Mohlig, M.2    Weickert, M.O.3
  • 60
    • 84861971962 scopus 로고    scopus 로고
    • Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men
    • Iranmanesh A, Lawson D, Veldhuis JD. Distinct metabolic surrogates predict basal and rebound GH secretion after glucose ingestion in men. J Clin Endocrinol Metab 2012;97:2172-9
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 2172-2179
    • Iranmanesh, A.1    Lawson, D.2    Veldhuis, J.D.3
  • 61
    • 84861455879 scopus 로고    scopus 로고
    • Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience
    • Minuto FM, Resmini E, Boschetti M, et al. Biochemical diagnosis and assessment of disease activity in acromegaly: A two-decade experience. Pituitary 2012;15:215-21
    • (2012) Pituitary , vol.15 , pp. 215-221
    • Minuto, F.M.1    Resmini, E.2    Boschetti, M.3
  • 62
    • 0030746256 scopus 로고    scopus 로고
    • In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion
    • Grottoli S, Procopio M, Maccario M, et al. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion. J Clin Endocrinol Metab 1997;82:2261-5
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 2261-2265
    • Grottoli, S.1    Procopio, M.2    MacCario, M.3
  • 63
    • 0028270653 scopus 로고
    • Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women
    • Chapman IM, Hartman ML, Straume M, et al. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 1994;78:1312-19
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 1312-1319
    • Chapman, I.M.1    Hartman, M.L.2    Straume, M.3
  • 64
    • 0036345609 scopus 로고    scopus 로고
    • Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up
    • Dimaraki EV, Jaffe CA, DeMott-Friberg R, et al. Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up. J Clin Endocrinol Metab 2002;87:3537-42
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 3537-3542
    • Dimaraki, E.V.1    Jaffe, C.A.2    Demott-Friberg, R.3
  • 65
    • 78751493190 scopus 로고    scopus 로고
    • Limited utility of oral glucose tolerance test in biochemically active acromegaly
    • had 0.4 mg/l and limited role of OGTT in patients with low GH secretion
    • Ribeiro-Oliveira A Jr, Faje AT, Barkan AL. Limited utility of oral glucose tolerance test in biochemically active acromegaly. Eur J Endocrinol 2011;164:17-22 had
    • (2011) Eur J Endocrinol , vol.164 , pp. 17-22
    • Ribeiro-Oliveira Jr., A.1    Faje, A.T.2    Barkan, A.L.3
  • 66
    • 0037318236 scopus 로고    scopus 로고
    • Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly
    • Grottoli S, Razzore P, Gaia D, et al. Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. J Endocrinol Invest 2003;26:123-7
    • (2003) J Endocrinol Invest , vol.26 , pp. 123-127
    • Grottoli, S.1    Razzore, P.2    Gaia, D.3
  • 67
    • 0031763448 scopus 로고    scopus 로고
    • Evaluation of disease status with sensitive measures of growth hormone secretion in postoperative patients with acromegaly
    • Freda PU, Post KD, Powell JS, et al. Evaluation of disease status with sensitive measures of growth hormone secretion in postoperative patients with acromegaly. J Clin Endocrinol Metab 1998;83:3808-16
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 3808-3816
    • Freda, P.U.1    Post, K.D.2    Powell, J.S.3
  • 68
    • 0023727258 scopus 로고
    • Growth factors and the thyroid: Effects of treatment for hyper- and hypothyroidism on serum IGF-I and urinary epidermal growth factor concentrations
    • Westermark K, Alm J, Skottner A, et al. Growth factors and the thyroid: Effects of treatment for hyper- and hypothyroidism on serum IGF-I and urinary epidermal growth factor concentrations. Acta Endocrinol (Copenh) 1988;118:415-21
    • (1988) Acta Endocrinol (Copenh , vol.118 , pp. 415-421
    • Westermark, K.1    Alm, J.2    Skottner, A.3
  • 69
    • 34249886308 scopus 로고    scopus 로고
    • IGF-I assays: Current assay methodologies and their limitations
    • Clemmons DR. IGF-I assays: Current assay methodologies and their limitations. Pituitary 2007;10:121-8
    • (2007) Pituitary , vol.10 , pp. 121-128
    • Clemmons, D.R.1
  • 70
    • 79956157928 scopus 로고    scopus 로고
    • Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays
    • Clemmons DR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem 2011;57:555-9
    • (2011) Clin Chem , vol.57 , pp. 555-559
    • Clemmons, D.R.1
  • 71
    • 59749084581 scopus 로고    scopus 로고
    • The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly
    • Carmichael JD, Bonert VS, Mirocha JM, et al. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab 2009;94:523-7
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 523-527
    • Carmichael, J.D.1    Bonert, V.S.2    Mirocha, J.M.3
  • 72
    • 46949108045 scopus 로고    scopus 로고
    • Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR
    • Machado EO, Taboada GF, Neto LV, et al. Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR. Growth Horm IGF Res 2008;18:389-93
    • (2008) Growth Horm IGF Res , vol.18 , pp. 389-393
    • MacHado, E.O.1    Taboada, G.F.2    Neto, L.V.3
  • 73
    • 84870320908 scopus 로고    scopus 로고
    • Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naive to medical therapy and radiation: What to follow, GH or IGF-1 values?
    • Brzana JA, Yedinak CG, Delashaw JB, et al. Discordant growth hormone and IGF-1 levels post pituitary surgery in patients with acromegaly naive to medical therapy and radiation: What to follow, GH or IGF-1 values? Pituitary 2012;15:562-70
    • (2012) Pituitary , vol.15 , pp. 562-570
    • Brzana, J.A.1    Yedinak, C.G.2    Delashaw, J.B.3
  • 74
    • 0027483351 scopus 로고
    • Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins
    • Miell JP, Taylor AM, Zini M, et al. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab 1993;76:950-5
    • (1993) J Clin Endocrinol Metab , vol.76 , pp. 950-955
    • Miell, J.P.1    Taylor, A.M.2    Zini, M.3
  • 75
    • 66749136426 scopus 로고    scopus 로고
    • Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly
    • Bianchi A, Giustina A, Cimino V, et al. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J Clin Endocrinol Metab 2009;94:2015-22
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 2015-2022
    • Bianchi, A.1    Giustina, A.2    Cimino, V.3
  • 76
    • 33644525358 scopus 로고    scopus 로고
    • Serum IGF-1 in treated acromegaly - How normal is normal?
    • Lansang C, Chitaia N, Simpson NE, et al. Serum IGF-1 in treated acromegaly - how normal is normal? Pituitary 2005;8:135-8
    • (2005) Pituitary , vol.8 , pp. 135-138
    • Lansang, C.1    Chitaia, N.2    Simpson, N.E.3
  • 78
    • 0035944825 scopus 로고    scopus 로고
    • Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
    • Van Der Lely AJ, Hutson RK, Trainer PJ, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 2001;358:1754-9
    • (2001) Lancet , vol.358 , pp. 1754-1759
    • Van Der Lely, A.J.1    Hutson, R.K.2    Trainer, P.J.3
  • 79
    • 76149125135 scopus 로고    scopus 로고
    • Growth hormone deficiency after treatment of acromegaly: A randomized, placebo-controlled study of growth hormone replacement
    • Miller KK, Wexler T, Fazeli P, et al. Growth hormone deficiency after treatment of acromegaly: A randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab 2010;95:567-77
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 567-577
    • Miller, K.K.1    Wexler, T.2    Fazeli, P.3
  • 81
    • 80054755358 scopus 로고    scopus 로고
    • Initial experience of 3 tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours
    • Stobo DB, Lindsay RS, Connell JM, et al. Initial experience of 3 tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours. Clin Endocrinol( Oxf ) 2011;75:673-7
    • (2011) Clin Endocrinol( Oxf , vol.75 , pp. 673-677
    • Stobo, D.B.1    Lindsay, R.S.2    Connell, J.M.3
  • 82
    • 84877122364 scopus 로고    scopus 로고
    • Acromegaly due to an ectopic pituitary adenoma in the clivus: Case report and review of literature
    • Appel JG, Bergsneider M, Vinters H, et al. Acromegaly due to an ectopic pituitary adenoma in the clivus: Case report and review of literature. Pituitary 2012;15:S53-6
    • (2012) Pituitary , vol.15
    • Appel, J.G.1    Bergsneider, M.2    Vinters, H.3
  • 83
    • 84862018622 scopus 로고    scopus 로고
    • Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
    • Heck A, Ringstad G, Fougner SL, et al. Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly. Clin Endocrinol (Oxf ) 2012;77:72-8
    • (2012) Clin Endocrinol (Oxf , vol.77 , pp. 72-78
    • Heck, A.1    Ringstad, G.2    Fougner, S.L.3
  • 84
    • 79955664599 scopus 로고    scopus 로고
    • Increased rate of intracranial saccular aneurysms in acromegaly: An MR angiography study and review of the literature
    • Manara R, Maffei P, Citton V, et al. Increased rate of intracranial saccular aneurysms in acromegaly: An MR angiography study and review of the literature. J Clin Endocrinol Metab 2011;96:1292-300
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 1292-300
    • Manara, R.1    Maffei, P.2    Citton, V.3
  • 85
    • 84878752414 scopus 로고    scopus 로고
    • Prevalence of cerebral aneurysm in patients with acromegaly
    • Oshino S, Nishino A, Suzuki T, et al. Prevalence of cerebral aneurysm in patients with acromegaly. Pituitary 2012;16:195-201
    • (2012) Pituitary , vol.16 , pp. 195-201
    • Oshino, S.1    Nishino, A.2    Suzuki, T.3
  • 87
    • 84888199902 scopus 로고    scopus 로고
    • Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: A large single center experience
    • Epub ahead of print
    • Brzana J, Yedinak CG, Gultekin SH, et al. Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: A large single center experience. Pituitary 2012. [Epub ahead of print
    • (2012) Pituitary
    • Brzana, J.1    Yedinak, C.G.2    Gultekin, S.H.3
  • 88
    • 84875156034 scopus 로고    scopus 로고
    • Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas
    • Larkin S, Reddy R, Karavitaki N, et al. Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas. Eur J Endocrinol 2013;168:491-9
    • (2013) Eur J Endocrinol , vol.168 , pp. 491-499
    • Larkin, S.1    Reddy, R.2    Karavitaki, N.3
  • 89
    • 84872070630 scopus 로고    scopus 로고
    • Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly
    • Gatto F, Feelders RA, Van Der Pas R, et al. Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2013;98:E66-71
    • (2013) J Clin Endocrinol Metab , vol.98
    • Gatto, F.1    Feelders, R.A.2    Van Der Pas, R.3
  • 90
    • 84898833299 scopus 로고    scopus 로고
    • Absence of immunostaining for growth hormone in a subset of patients with acromegaly
    • Epub ahead of print
    • Schroeder JL, Spiotta AM, Fleseriu M, et al. Absence of immunostaining for growth hormone in a subset of patients with acromegaly. Pituitary 2013; Epub ahead of print
    • (2013) Pituitary
    • Schroeder, J.L.1    Spiotta, A.M.2    Fleseriu, M.3
  • 91
    • 77956574952 scopus 로고    scopus 로고
    • Approach to the patient with persistent acromegaly after pituitary surgery
    • Katznelson L. Approach to the patient with persistent acromegaly after pituitary surgery. J Clin Endocrinol Metab 2010;95:4114-23
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 4114-4123
    • Katznelson, L.1
  • 92
    • 79958135906 scopus 로고    scopus 로고
    • Efficacy and complications of neurosurgical treatment of acromegaly
    • Krzentowska-Korek A, Golkowski F, Baldys-Waligorska A, et al. Efficacy and complications of neurosurgical treatment of acromegaly. Pituitary 2011;14:157-62
    • (2011) Pituitary , vol.14 , pp. 157-162
    • Krzentowska-Korek, A.1    Golkowski, F.2    Baldys-Waligorska, A.3
  • 93
    • 84862114485 scopus 로고    scopus 로고
    • The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: Clinical analysis of 279 cases
    • Wang M, Mou C, Jiang M, et al. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: Clinical analysis of 279 cases. Eur J Endocrinol 2012;166:797-802
    • (2012) Eur J Endocrinol , vol.166 , pp. 797-802
    • Wang, M.1    Mou, C.2    Jiang, M.3
  • 94
    • 0021809469 scopus 로고
    • Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy
    • Takamoto S, Tsuchiya H, Onishi T, et al. Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy. J Clin Endocrinol Metab 1985;61:7-11
    • (1985) J Clin Endocrinol Metab , vol.61 , pp. 7-11
    • Takamoto, S.1    Tsuchiya, H.2    Onishi, T.3
  • 95
    • 84858160589 scopus 로고    scopus 로고
    • Pregnancy and acromegaly: A review
    • Cheng V, Faiman C, Kennedy L, et al. Pregnancy and acromegaly: A review. Pituitary 2012;15:59-63
    • (2012) Pituitary , vol.15 , pp. 59-63
    • Cheng, V.1    Faiman, C.2    Kennedy, L.3
  • 96
  • 97
    • 2442473829 scopus 로고    scopus 로고
    • Activating gsalpha mutations: Analysis of 113 patients with signs of McCune-albright syndrome-a european collaborative study
    • European Collaborative Study
    • Lumbroso S, Paris F, Sultan C. European Collaborative Study. Activating gsalpha mutations: Analysis of 113 patients with signs of McCune-albright syndrome-a european collaborative study. J Clin Endocrinol Metab 2004;89:2107-13
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 2107-2113
    • Lumbroso, S.1    Paris, F.2    Sultan, C.3
  • 98
    • 84863569161 scopus 로고    scopus 로고
    • Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-albright syndrome
    • Vortmeyer AO, Glasker S, Mehta GU, et al. Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-albright syndrome. J Clin Endocrinol Metab 2012;97:2404-13
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 2404-2413
    • Vortmeyer, A.O.1    Glasker, S.2    Mehta, G.U.3
  • 99
    • 18244392974 scopus 로고    scopus 로고
    • Pituitary disease in MEN type 1( MEN1): Data from the france-belgium MEN1 multicenter study
    • Verges B, Boureille F, Goudet P, et al. Pituitary disease in MEN type 1( MEN1): Data from the france-belgium MEN1 multicenter study. J Clin Endocrinol Metab 2002;87:457-65
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 457-465
    • Verges, B.1    Boureille, F.2    Goudet, P.3
  • 100
    • 0033767048 scopus 로고    scopus 로고
    • Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (carney complex
    • Pack SD, Kirschner LS, Pak E, et al. Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (carney complex). J Clin Endocrinol Metab 2000;85:3860-5
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 3860-3865
    • Pack, S.D.1    Kirschner, L.S.2    Pak, E.3
  • 101
    • 79951999077 scopus 로고    scopus 로고
    • Familial isolated pituitary adenomas experience at a single center: Clinical importance of AIP mutation screening
    • Pinho LK, Vieira Neto L, Wildemberg LE, et al. Familial isolated pituitary adenomas experience at a single center: Clinical importance of AIP mutation screening. Arq Bras Endocrinol Metabol 2010;54:698-704
    • (2010) Arq Bras Endocrinol Metabol , vol.54 , pp. 698-704
    • Pinho, L.K.1    Vieira Neto, L.2    Wildemberg, L.E.3
  • 102
    • 77954316421 scopus 로고    scopus 로고
    • Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA
    • Chahal HS, Chapple JP, Frohman LA, et al. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab 2010;21:419-27
    • (2010) Trends Endocrinol Metab , vol.21 , pp. 419-427
    • Chahal, H.S.1    Chapple, J.P.2    Frohman, L.A.3
  • 103
    • 84883194585 scopus 로고    scopus 로고
    • Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone( GHRH): A french nationwide series of 21 cases
    • Garby L, Caron P, Claustrat F, et al. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone( GHRH): A french nationwide series of 21 cases. J Clin Endo
    • J Clin Endo
    • Garby, L.1    Caron, P.2    Claustrat, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.